You're absolutely right.
First, it is critical that people have access to the test strips they need based on their experience of diabetes, and that really varies from individual to individual. That's why we stress that coverage for devices and supplies such as test strips must be part of a national pharmacare approach, because that is just as critical as the insulin or the metformin those people need to live.
You're also right that the provinces have a critical role to play in implementing this strategy. Really, the diabetes 360° recommendations are founded on the basis that we will collaborate with the provinces and the territories in order to implement them. We want to create greater alignment from one province to another, wherever possible, in the coverage available. We think this is possible based on the state of negotiations we've been having with the provinces to date.